ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Adjuvant Chemotherapy for Patients with Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Multicenter, Observational Study

Nie, Run-Cong; Luo, Tian-Qi; Li, Guo-Dong; Zhang, Fei-Yang; Chen, Guo-Ming; Li, Jin-Xing; Chen, Xiao-Jiang; Zhao, Zhou-Kai; Jiang, Kai-Ming; Wei, Yi-Cheng; Huang, Ming-Wei*; Chen, Shi*; Chen, Ying-Bo*哈尔滨医科大学; 中山大学; 6
Annals of Surgical Oncology2022-12-24DOI: 10.1245/s10434-022-12830-4
2被引11阅读
引用收藏
分享

摘要

Background. Although the incidence of adenocarcinoma of the esophagogastric junction (AEG) has been increasing since the past decade, the proportion of AEG cases in two previous clinical trials (ACTS-GC and CLASSIC) that investigated the efficacy of adjuvant chemotherapy was relatively small. Therefore, whether AEG patients can benefit from adjuvant chemotherapy remains unclear.Methods. Patients who were diagnosed with pathological stage II/III, Siewert II/III AEG, and underwent curative surgery at three high-volume institutions were assessed. Clinical outcomes were analyzed by using Kaplan-Meier curves, log-rank test, and Cox regression model. Propensity score matching (PSM) was used to reduce the selection bias.Results .A total of 927 patients were included (the chemotherapy group: 696 patients; the surgery-only group: 231 patients). The median follow-up was 39.0 months. The 5-year overall survival was 63.1% (95% confidence interval [CI]: 59.0-67.6%) for the chemotherapy group and 50.2% in the surgery-only group (hazard ratio [HR] = 0.69, 95% CI: 0.54-0.88; p = 0.003). The 5-year, disease-free survival was 35.4% for the chemotherapy group and 16.6% for the surgery-only group (HR = 0.66, 95% CI: 0.53-0.83; p < 0.001). After PSM, the survival benefit of adjuvant chemotherapy for AEG was maintained. Multivariate analysis for overall survival and disease-free survival further demonstrated the survival benefit of adjuvant chemotherapy, with HRs of 0.63 (p < 0.001) and 0.52 (p < 0.001), respectively.Conclusions .Postoperative adjuvant chemotherapy was associated with improved overall survival and disease-free survival in patients with operable stage II or III AEG after D2 gastrectomy.

学科与关键词

关键词
GASTRIC-CANCERPERIOPERATIVE CHEMOTHERAPYOPEN-LABELSURGERYCAPECITABINEOXALIPLATIN
相关
加载中…
  • ASO Visual Abstract: Adjuvant Chemotherapy for Patients with Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Multicenter Observational Study
    Nie, Run-Cong; Luo, Tian-Qi; Li, Guo-Dong; Zhang, Fei-Yang; Chen, Guo-Ming; Li, Jin-Xing; Chen, Xiao-Jiang; Zhao, Zhou-Kai; Jiang, Kai-Ming; Wei, Yi-Cheng; Hang, Ming-Wei*; Chen, Shi*; Chen, Ying-Bo*Annals of Surgical Oncology, 2023.
  • Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study
    Liang, Yanrui*; Zhao, Liying; Chen, Hao; Lin, Tian; Chen, Tao; Zhao, Mingli; Hu, Yanfeng; Yu, Jiang; Liu, Hao; Li, GuoxinBMC CANCER, 2021, 21(1): 196.被引 10
  • Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma
    He Ming Ming; Zhang Dong Sheng; Wang Feng; Wang Zhi Qiang; Luo Hui Yan; Ren Chao; Jin Ying; Chen Dong Liang; Xu Rui Hua*World Journal of Gastroenterology, 2014, 20(1): 264-273.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Annals of Surgical Oncology
发表日期
2022-12-24
DOI
10.1245/s10434-022-12830-4
语言
ENGLISH
期刊等级
2区
成果收录
SCIE

作者

  • N

    Nie, Run-Cong (第一作者)

    sun yat sen univ

  • L

    Luo, Tian-Qi

    sun yat sen univ

查看全部 13 位作者收起作者
  • L

    Li, Guo-Dong

    harbin med univ

  • Z

    Zhang, Fei-Yang

    sun yat sen univ

  • C

    Chen, Guo-Ming

    sun yat sen univ

  • L

    Li, Jin-Xing

    harbin med univ

  • C

    Chen, Xiao-Jiang

    sun yat sen univ

  • Z

    Zhao, Zhou-Kai

    sun yat sen univ

  • J

    Jiang, Kai-Ming

    sun yat sen univ

  • W

    Wei, Yi-Cheng

    sun yat sen univ

  • H

    Huang, Ming-Wei (通讯)

    guangxi med univ

  • C

    Chen, Shi (通讯)

    6 · sun yat sen univ

  • C

    Chen, Ying-Bo (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417